Last reviewed · How we verify

NCT06695858

The Incidence of Post-Operative Lung Atelectasis With Erector Spinae Plane Block in Bariatric Surgery:

Completed Phase 3 Last updated 18 November 2025
What this trial tests

Phase 3 trial testing ESPB in Pulmonary Atelectasis in 138 participants. Completed in 18 October 2025.

Timeline
15 November 2024
Primary endpoint
18 October 2025
18 October 2025

Quick facts

Lead sponsorKasr El Aini Hospital
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment138
Start date15 November 2024
Primary completion18 October 2025
Estimated completion18 October 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

Adults 18 to 60, any sex, with Pulmonary Atelectasis or Bariatric Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aim to compare the incidence of post-operative lung atelectasis with erector spinae plane block versus systemic analgesia in patients undergoing bariatric surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ESPB

Trials testing the same drug.

Other recruiting trials for Pulmonary Atelectasis

Currently open trials in the same condition.

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06695858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing